• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镰状细胞病患儿的静脉血栓栓塞症:一项回顾性队列研究。

Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study.

机构信息

Division of Pediatric Hematology/Oncology, Children's Hospital of the King's Daughters, Norfolk, VA.

Division of Pediatric Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI.

出版信息

J Pediatr. 2018 Jun;197:186-190.e1. doi: 10.1016/j.jpeds.2018.01.073. Epub 2018 Mar 28.

DOI:10.1016/j.jpeds.2018.01.073
PMID:29605397
Abstract

OBJECTIVES

To describe the cumulative incidence of venous thromboembolism (VTE) in children with sickle cell disease (SCD) followed at a single institution and report on the risk factors associated with VTE development.

STUDY DESIGN

Charts for all patients with SCD, aged 0-21 years, followed at Nationwide Children's Hospital over a 6-year period (January 1, 2009, to January 31, 2015) were reviewed. Data on VTE diagnosis, sex, body mass index/weight-for-length, SCD genotype, SCD clinical complications, central venous catheter (CVC) placement, and thrombophilia testing were collected.

RESULTS

Cumulative incidence of VTE in children with SCD followed at a single tertiary care institution was found to be 2.9% (12/414). Nine of the 12 VTE were CVC-associated. On univariate analysis, hemoglobin SS genotype (OR 10.7, 95% CI 1.4-83.5), CVC presence (OR 34.4, 95% CI 8.9-134.6), central nervous system vasculopathy (OR 19.4, 95% CI 5.6-63.4), chronic transfusion therapy (OR 30.6, 95% CI 8.9-122.2), and older age (P = .03) were associated with VTE. However, presence of CVC was the only independent risk factor identified on multivariable logistic regression analysis (OR 33.8, 95% CI 8.7-130.9).

CONCLUSION

In our institution, nearly 3% of children with SCD had a history of VTE. CVC is an independent predictor of VTE in children with SCD.

摘要

目的

描述在单一机构接受治疗的镰状细胞病(SCD)患儿静脉血栓栓塞症(VTE)的累积发病率,并报告与 VTE 发展相关的危险因素。

研究设计

回顾了在 Nationwide Children's Hospital 接受治疗的 6 年间(2009 年 1 月 1 日至 2015 年 1 月 31 日)所有 0-21 岁 SCD 患儿的图表。收集了 VTE 诊断、性别、体重指数/体重与身高比、SCD 基因型、SCD 临床并发症、中心静脉导管(CVC)置管和血栓形成倾向检测的数据。

结果

在一家三级保健机构接受治疗的 SCD 患儿的 VTE 累积发病率为 2.9%(12/414)。12 例 VTE 中有 9 例与 CVC 相关。单因素分析显示,血红蛋白 SS 基因型(OR 10.7,95%CI 1.4-83.5)、CVC 存在(OR 34.4,95%CI 8.9-134.6)、中枢神经系统血管病变(OR 19.4,95%CI 5.6-63.4)、慢性输血治疗(OR 30.6,95%CI 8.9-122.2)和年龄较大(P=0.03)与 VTE 相关。然而,CVC 的存在是多变量逻辑回归分析确定的唯一独立危险因素(OR 33.8,95%CI 8.7-130.9)。

结论

在我们的机构中,近 3%的 SCD 患儿有 VTE 病史。CVC 是 SCD 患儿 VTE 的独立预测因素。

相似文献

1
Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study.镰状细胞病患儿的静脉血栓栓塞症:一项回顾性队列研究。
J Pediatr. 2018 Jun;197:186-190.e1. doi: 10.1016/j.jpeds.2018.01.073. Epub 2018 Mar 28.
2
Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study.镰状细胞病患儿静脉血栓栓塞症的患病率及危险因素:一项行政数据库研究。
Blood Adv. 2018 Feb 13;2(3):285-291. doi: 10.1182/bloodadvances.2017012336.
3
Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.镰状细胞病合作研究中的静脉血栓栓塞发生率。
J Thromb Haemost. 2014 Dec;12(12):2010-6. doi: 10.1111/jth.12744. Epub 2014 Oct 18.
4
Hospital acquired venous thromboembolism in children with sickle cell disease.儿童镰状细胞病医院获得性静脉血栓栓塞症。
Pediatr Hematol Oncol. 2024 Oct;41(7):459-469. doi: 10.1080/08880018.2024.2362147. Epub 2024 Jun 5.
5
High incidence of venous thromboembolism recurrence in patients with sickle cell disease.镰状细胞病患者静脉血栓栓塞复发率高。
Am J Hematol. 2019 Aug;94(8):862-870. doi: 10.1002/ajh.25508. Epub 2019 Jun 12.
6
Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.镰状细胞病患者静脉血栓栓塞症发病率增加:危险因素、复发情况及对死亡率的影响。
Br J Haematol. 2017 Jul;178(2):319-326. doi: 10.1111/bjh.14655. Epub 2017 Apr 3.
7
Venous thromboembolism in children with cystic fibrosis: Retrospective incidence and intrapopulation risk factors.囊性纤维化患儿的静脉血栓栓塞症:回顾性发生率和人群内风险因素。
Thromb Res. 2017 Oct;158:161-166. doi: 10.1016/j.thromres.2017.08.022. Epub 2017 Sep 5.
8
Venous thromboembolism in children with central nervous system tumors: Comparison of an institutional cohort to a national administrative database.儿童中枢神经系统肿瘤的静脉血栓栓塞症:机构队列与国家行政数据库的比较。
Pediatr Blood Cancer. 2021 Mar;68(3):e28846. doi: 10.1002/pbc.28846. Epub 2020 Dec 19.
9
Hospital-associated venous thromboembolism in children: incidence and clinical characteristics.儿童医院相关性静脉血栓栓塞症:发生率及临床特征。
J Pediatr. 2014 Feb;164(2):332-8. doi: 10.1016/j.jpeds.2013.10.025. Epub 2013 Dec 12.
10
Incidence of venous thromboembolism in patients with sickle cell disease undergoing noncardiovascular surgery.镰状细胞病患者行非心血管手术时静脉血栓栓塞症的发生率。
J Vasc Surg Venous Lymphat Disord. 2023 May;11(3):543-552. doi: 10.1016/j.jvsv.2022.11.004. Epub 2022 Dec 24.

引用本文的文献

1
A Comparative Analysis of Hydroxyurea Treatment on Coagulation Profile Among Sickle Cell Anaemia Children in Lagos, Nigeria.尼日利亚拉各斯镰状细胞贫血儿童中羟基脲治疗对凝血指标影响的比较分析
Adv Hematol. 2024 Nov 23;2024:5002373. doi: 10.1155/ah/5002373. eCollection 2024.
2
Proportion and risk factors for hospital-acquired venous thromboembolism in children: a systematic review and meta-analysis of data from 20 million individuals in 22 countries.儿童医院获得性静脉血栓栓塞的比例及危险因素:对22个国家2000万人数据的系统评价和荟萃分析
Res Pract Thromb Haemost. 2024 Aug 5;8(6):102541. doi: 10.1016/j.rpth.2024.102541. eCollection 2024 Aug.
3
Predicting risk factors for thromboembolic complications in patients with sickle cell anaemia - lessons learned for prophylaxis.
预测镰状细胞贫血患者血栓栓塞并发症的风险因素 - 预防的经验教训。
J Int Med Res. 2021 Dec;49(12):3000605211055385. doi: 10.1177/03000605211055385.
4
Evaluation of point-of-care International Normalized Ratio in sickle cell disease.镰状细胞病即时国际标准化比值的评估。
Res Pract Thromb Haemost. 2021 May 27;5(4):e12533. doi: 10.1002/rth2.12533. eCollection 2021 May.
5
Clinical, laboratory, and genetic risk factors for thrombosis in sickle cell disease.镰状细胞病血栓形成的临床、实验室及遗传风险因素
Blood Adv. 2020 May 12;4(9):1978-1986. doi: 10.1182/bloodadvances.2019001384.
6
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.美国血液学会 2019 年镰状细胞病指南:心肺和肾脏疾病。
Blood Adv. 2019 Dec 10;3(23):3867-3897. doi: 10.1182/bloodadvances.2019000916.
7
Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.镰状细胞病中的血管不稳定与神经病变:一个综合框架
Front Neurol. 2019 Aug 13;10:871. doi: 10.3389/fneur.2019.00871. eCollection 2019.
8
Treatment-Related Outcomes in Paget-Schroetter Syndrome-A Cross-Sectional Investigation.Paget-Schroetter 综合征的治疗相关结局:一项横断面研究。
J Pediatr. 2019 Apr;207:226-232.e1. doi: 10.1016/j.jpeds.2018.11.018. Epub 2018 Dec 7.